
NCS Multistage Holdings, Inc. (NASDAQ:NCSM – Free Report) – Singular Research issued their FY2025 earnings per share (EPS) estimates for NCS Multistage in a research note issued on Tuesday, November 11th. Singular Research analyst G. Sriharan forecasts that the company will post earnings of $3.91 per share for the year. Singular Research currently has a “Strong-Buy” rating on the stock. Singular Research also issued estimates for NCS Multistage’s Q4 2025 earnings at $0.70 EPS, Q1 2026 earnings at $1.49 EPS, Q2 2026 earnings at $0.15 EPS, Q3 2026 earnings at $1.25 EPS, Q4 2026 earnings at $1.22 EPS and FY2026 earnings at $4.11 EPS.
NCS Multistage (NASDAQ:NCSM – Get Free Report) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.20. NCS Multistage had a net margin of 6.89% and a return on equity of 12.27%. The company had revenue of $46.54 million during the quarter, compared to the consensus estimate of $46.10 million.
Get Our Latest Stock Report on NCS Multistage
NCS Multistage Price Performance
Shares of NCSM opened at $38.33 on Thursday. The firm has a market capitalization of $97.39 million, a price-to-earnings ratio of 8.44 and a beta of 0.79. The firm’s fifty day simple moving average is $43.78 and its 200-day simple moving average is $36.11. NCS Multistage has a twelve month low of $20.00 and a twelve month high of $53.69. The company has a current ratio of 4.66, a quick ratio of 2.83 and a debt-to-equity ratio of 0.04.
Insider Buying and Selling at NCS Multistage
In related news, Director Robert Nipper sold 1,000 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $40.00, for a total transaction of $40,000.00. Following the transaction, the director owned 33,455 shares of the company’s stock, valued at $1,338,200. This trade represents a 2.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 10.00% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Empowered Funds LLC increased its holdings in shares of NCS Multistage by 7.3% in the first quarter. Empowered Funds LLC now owns 21,489 shares of the company’s stock valued at $752,000 after purchasing an additional 1,455 shares during the period. Dimensional Fund Advisors LP grew its position in NCS Multistage by 7.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 17,473 shares of the company’s stock valued at $892,000 after buying an additional 1,200 shares during the last quarter. Inspire Advisors LLC acquired a new position in NCS Multistage in the 2nd quarter valued at $430,000. Bailard Inc. raised its position in NCS Multistage by 26.1% during the 3rd quarter. Bailard Inc. now owns 8,687 shares of the company’s stock worth $444,000 after buying an additional 1,800 shares during the last quarter. Finally, NewEdge Advisors LLC raised its position in NCS Multistage by 3,774.4% during the 2nd quarter. NewEdge Advisors LLC now owns 8,175 shares of the company’s stock worth $241,000 after buying an additional 7,964 shares during the last quarter. 70.91% of the stock is currently owned by hedge funds and other institutional investors.
NCS Multistage Company Profile
NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and construction, and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, and sand jet perforating products; enhanced recovery products, such as sliding sleeve, as well as Terrus system, an injection control device; repeat precision products comprising composite frac plugs and bridge plugs, single-use disposable setting tools, express systems, and related products; chemical and radioactive tracer diagnostics services; and well construction products, including AirLock casing buoyancy system, Vecturon and Vectraset liner hanger systems, and Toe initiation sleeves.
Read More
- Five stocks we like better than NCS Multistage
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Reasons On Holding’s Sell-Off Is Over and New Highs Are Coming
- The How And Why of Investing in Oil Stocks
- As Warren Buffett Nears His Exit, Berkshire’s Amassed Record Cash
- Industrial Products Stocks Investing
- Rare Earth Stocks: The Truce That Isn’t a Truce
Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with MarketBeat.com's FREE daily email newsletter.
